Is intestinal oxidative stress involved in patients with compensated liver cirrhosis?
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 3
Abstract
Background. Liver cirrhosis is associated with intestinal epithelial barrier dysfunction, which may be affected by oxidative stress.Studies in cirrhotic rats provided evidence for intestinal oxidative stress, but studies in cirrhotic patients are scarce. We have shownintestinal barrier dysfunction in patients with compensated cirrhosis. Aim. The present study aimed to investigate whether oxidative stress occurs in the intestinal mucosa of compensated cirrhotic patients and may contribute to barrier dysfunction. Material and methods. Oxidative stress was studied in duodenal and sigmoid biopsies from 15 cirrhotic patients and 22 controls by analyzing transcription of genes involved in glutathione and uric acid metabolism using quantitative real-time polymerase chain reaction. Protein levels of glutathione and glutathione disulphide were measured and the glutathione/glutathione disulphide ratio was calculated as marker of oxidative stress. In addition, intestinal myeloperoxidase and fecal calprotectin were determined. Results. Gene transcription of glutathione synthetase and glutathione reductase were significantly different in duodenal and sigmoid biopsies of cirrhotic patients vs. controls, but no alterations were found for other genes nor for glutathione, glutathione disulphide, glutathione/glutathione disulphide ratio and intestinal myeloperoxidase and fecal calprotectin concentrations. Conclusion. This study did not find indications for oxidative stress and low-grade inflammation in the small and large intestine of stable compensated cirrhotic patients. Although these preliminary findings need further validation, we found intestinal oxidative stress not to be a major mechanism contributing to epitelial barrier dysfunction in patients with compensated cirrhosis.
Authors and Affiliations
Kirsten Pijls, Daisy Jonkers, Marie-Jose Drittij-Reijnders, Montserrat Elizalde, Guido Haenen, Aalt Bast, Ad Masclee, Ger Koek
Keywords
Related Articles
- EP ID EP78581
- DOI 10.5604/16652681.1198816
- Views 94
- Downloads 0
Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease
Background. Osteocalcin is a hormone with a complex cross-talk between adipose tissue and the skeleton. The aim of the present study was to explore the relation of osteocalcin with histopathological changes of NALFD pati...
Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal stat
Introduction. Liver disease is a major health issue in Mexico. Although several studies have been performed to analyze the impact of liver diseases on the Mexican population, none has compared the prevalence and impact o...
Minimal hepatic encephalopathy in cirrhosis- how long to treat?
Introduction. Minimal hepatic encephalopathy (MHE) can reverse after short-term treatment. However, relapse rate of MHE after stopping treatment has not been studied so far. We aimed to evaluate long-term (9 months) effi...
Predictive factors of abstinence in patients undergoing liver transplantation for alcoholic liver disease
Introduction. Alcoholic cirrhosis is one of the most common indications for liver transplantation (LT) inwestern countries. A major concern about transplant patients due to alcoholic liver disease (ALD) is alcoholic reci...
Kava hepatotoxicity - a clinical review
This review critically analyzes the clinical data of patients with suspected kava hepatotoxicity and suggests recommendations for minimizing risk. Kava is a plant (Piper methysticum) of the pepper family Piperaceae, and...